117 related articles for article (PubMed ID: 35854067)
1. Idelalisib inhibits experimental proliferative vitroretinopathy.
Dong L; Han H; Huang X; Ma G; Fang D; Qi H; Han Z; Wang L; Tian J; Vanhaesebroeck B; Zhang G; Zhang S; Lei H
Lab Invest; 2022 Dec; 102(12):1296-1303. PubMed ID: 35854067
[TBL] [Abstract][Full Text] [Related]
2. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes.
Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H
Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
[TBL] [Abstract][Full Text] [Related]
5. NFκB-Mediated Expression of Phosphoinositide 3-Kinase δ Is Critical for Mesenchymal Transition in Retinal Pigment Epithelial Cells.
Han H; Yang Y; Han Z; Wang L; Dong L; Qi H; Liu B; Tian J; Vanhaesebroeck B; Kazlauskas A; Zhang G; Zhang S; Lei H
Cells; 2023 Jan; 12(2):. PubMed ID: 36672142
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.
Han H; Chen N; Huang X; Liu B; Tian J; Lei H
J Biol Chem; 2019 Oct; 294(42):15408-15417. PubMed ID: 31467081
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib prevents TGF-β2-induced epithelial-mesenchymal transition in retinal pigment epithelial cells.
Yin Y; Liu S; Pu L; Luo J; Liu H; Wu W
Biomed Pharmacother; 2023 May; 161():114543. PubMed ID: 36933383
[TBL] [Abstract][Full Text] [Related]
9. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
[TBL] [Abstract][Full Text] [Related]
10. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
Ishikawa K
Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
[TBL] [Abstract][Full Text] [Related]
11. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by female sex hormones of collagen gel contraction mediated by retinal pigment epithelial cells.
Kimura K; Orita T; Fujitsu Y; Liu Y; Wakuta M; Morishige N; Suzuki K; Sonoda KH
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2621-30. PubMed ID: 24609629
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
[TBL] [Abstract][Full Text] [Related]
14. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
15. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
[TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.
Zhang W; Li J
J Cell Mol Med; 2021 Nov; 25(21):10213-10223. PubMed ID: 34598306
[TBL] [Abstract][Full Text] [Related]
17. Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition.
Jiang H; Chen Y; He Z; Li J; Gao Q; Li W; Wei W; Zhang Y
Biochem Biophys Res Commun; 2023 Dec; 686():149149. PubMed ID: 37918204
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
19. p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model.
Zhang Q; Guo Y; Kang M; Lin WH; Wu JC; Yu Y; Li LC; Sang A
PLoS One; 2023; 18(2):e0282063. PubMed ID: 36821623
[TBL] [Abstract][Full Text] [Related]
20. Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells.
Ko JA; Sotani Y; Ibrahim DG; Kiuchi Y
Cell Biochem Funct; 2017 Oct; 35(7):426-432. PubMed ID: 28906008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
